Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

For many investors, the main point of stock picking is to generate higher returns than the overall market. But the ...

Pfizer’s 7%+ yield is tempting, but rising political, regulatory, and business risks threaten its stability and growth ...

Discover 23 high-dividend stocks that outshine treasuries! Learn why growing dividends signal financial strength and explore ...

Drug company shares are down amid President Donald Trump’s assault on the industry, but some in Congress see value.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Pfizer PFE is likely to encounter several headwinds in the next couple of years that can hurt its sales and profits, the ...

Pfizer (NYSE:PFE) stock is a biopharmaceutical firm that had a magnificent breakout in 2021 as the worst of the pandemic sent ...

View the latest Pfizer Inc. (PFE) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Pfizer's stock, after facing post-pandemic market blues, is showing glimmers of a comeback. The stock recently logged a 4.10% ...

Detailed price information for Realty Income Corp (O-N) from The Globe and Mail including charting and trades.